Latest News
REFINE trials opens their melanoma cohort
REFINE trial opens their melanoma cohort
Whole body application of CHG antiseptic is safe for hospitalised, premature newborns
A commonly used antiseptic is safe to apply on the skin of premature newborns, according to results from the NeoCHG pilot trial presented today at the 2023 ECCMID conference in Copenhagen.
World-first multi-arm multi-stage trial for progressive MS opens
Octopus, a world-first multi-arm multi-stage trial for people living with progressive multiple sclerosis, has opened for participants in the UK.